1. Home
  2. CRNX vs MMS Comparison

CRNX vs MMS Comparison

Compare CRNX & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$47.18

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo Maximus Inc.

MMS

Maximus Inc.

HOLD

Current Price

$84.57

Market Cap

4.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
MMS
Founded
2008
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
4.7B
IPO Year
2018
1997

Fundamental Metrics

Financial Performance
Metric
CRNX
MMS
Price
$47.18
$84.57
Analyst Decision
Buy
Buy
Analyst Count
11
1
Target Price
$71.00
$90.00
AVG Volume (30 Days)
1.4M
669.4K
Earning Date
11-06-2025
11-20-2025
Dividend Yield
N/A
1.42%
EPS Growth
N/A
10.42
EPS
N/A
5.51
Revenue
$1,535,000.00
$5,431,276,000.00
Revenue This Year
$425.31
$1.71
Revenue Next Year
$943.50
$4.98
P/E Ratio
N/A
$15.37
Revenue Growth
47.74
2.36
52 Week Low
$24.10
$63.77
52 Week High
$60.34
$92.50

Technical Indicators

Market Signals
Indicator
CRNX
MMS
Relative Strength Index (RSI) 61.29 50.79
Support Level $44.52 $85.53
Resistance Level $48.62 $87.92
Average True Range (ATR) 2.00 2.43
MACD 0.29 0.32
Stochastic Oscillator 72.38 62.49

Price Performance

Historical Comparison
CRNX
MMS

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: